Japan is introducing a self-amplifying mRNA COVID-19 vaccine as part of its vaccination program for the coming year, which will target people 65 and older.
Jan approved the jab despite just one showing a 90 percent adverse event rate.
Worse, the United States is next in line to approve these jabs.
ARCT-154, which was approved by Japan’s Ministry of Health, Labour, and Welfare in November 2023, is the world’s first self-amplifying mRNA COVID-19 vaccine
Biotechnology firm CSL developed the vaccine in collaboration with Arcturus Therapeutics.
Unlike mRNA vaccines, saRNA vaccines create copies of themselves and their encoded proteins, essentially amplifying the vaccine’s presence in the body.
According to CSL, when compared with the he mRNA vaccines, the saRNA demonstrated higher immunogenicity and a favorable safety profile.
However, independent vaccine researchers said due to the technology being tested, it is incredibly dangerous.
“These products are completely new. There is absolutely no long-term safety data on them,” Dr. Nicolas Hulscher stated.
He noted that in trials for ARCT-154, a nearly 90 percent adverse event rate was recorded, with significant systemic reactions in participants.
Karina Acevedo Whitehouse, a microbiology professor, warned of the lack of testing and studies of self-amplifying mRNA technology, adding that there are no assessments of potential cellular transformations, including cancer.
RELATED: Florida Woman, 23, Left Blind After Being Forced to Take 3 Vaccine injections
We simply do not know what the consequences could be,” she warned.
“There have also been no studies conducted on trans-generational effects — for instance, teratogenicity [birth defects] — of self-amplifying mRNA injections,” she said. “We simply do not know what the consequences could be.”
Meanwhile, a Cambridge University study revealed that original mRNA vaccines may rigger unintended immune responses, leading to possible autoimmune reactions.
Whitehouse linked the increase of turbo cancers to the effects of mRNA technology on cellular pathways.
However, self-amplifying mRNA vaccines may pose even greater risks than the original mRNA vaccines, with experts warning it could become “conventional mRNA injections on steroids,”
The U.S. is already planning to use the new vaccines, with the Biden administration partnering with several companies to develop self-amplifying mRNA vaccines for future pandemics.
In simpler terms, big pharma is conspiring to create a line of self-amplifying vaccines to profit from future pandemics,
CastleVax, Codagenix, and Gritstone Bio have already been awarded contracts from the Department of Health and Human Services under the federal government’s Project NextGen.
Project NextGen aims to rapidly develop the next generation of vaccines.
Last year, Gritstone Bio locked in a $433 million contract to “conduct a mid-stage study of its self-amplifying mRNA COVID-19 vaccine candidate.”
Gritstone Bio has previously received funding from Bill Gates and partners with BlackRock and State Street, which are official partners of the World Economic Forum.
